Acasă › Schizofrenie › Georgia

Studii clinice pentru Schizofrenie în Georgia

29 studii pentru Schizofrenie caută participanți în Georgia.

Orașe în Georgia

Text oficial al studiului (în engleză)

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

Vanda Investigational Site, Atlanta
Vanda Investigational Site, Atlanta
Vanda Investigational Site, Decatur

În curs de recrutareFaza 4

Vârste de la 12 la 17 · Toate sexele · Actualizat 1 oct. 2026 · NCT05648591

A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia

Synexus Clinical Research US Inc, Atlanta

În curs de recrutareFaza 1

Vârste de la 18 la 55 · Toate sexele · Actualizat 28 sept. 2026 · NCT07615426

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

Atlanta Center for Medical Research, Atlanta
Local Institution - 0070, Sandy Springs
Local Institution - 0189, Savannah

În curs de recrutareFaza 3

Vârste de la 18 la 65 · Toate sexele · Actualizat 28 sept. 2026 · NCT07686263

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

CenExeli Research LLC, Atlanta
Atlanta Center for Medical Research, Atlanta
CenExeli Research LLC 1, Savannah

În curs de recrutareFaza 3

Vârste de la 5 la 17 · Toate sexele · Actualizat 25 sept. 2026 · NCT06229210

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

Neurocrine Clinical Site, Atlanta
Neurocrine Clinical Site, Atlanta
Neurocrine Clinical Site, Decatur
și încă 1

În curs de recrutareFaza 3

Vârste de la 18 la 65 · Toate sexele · Actualizat 25 sept. 2026 · NCT07114874

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

Neurocrine Clinical Site, Atlanta

În curs de recrutareFaza 3

Vârste de la 18 la 65 · Toate sexele · Actualizat 25 sept. 2026 · NCT07227818

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

Atlanta Center for Medical Research, Atlanta
Salveo Integrative Health - Lawrenceville, Lawrenceville
Denali Health Atlanta, LLC, Stone Mountain

În curs de recrutareFaza 3

Vârste de la 5 la 17 · Toate sexele · Actualizat 22 sept. 2026 · NCT07424404

A Study of Brenipatide in Adult Participants With Schizophrenia

Atlanta Center for Medical Research, Atlanta
Augusta University, Augusta

În curs de recrutareFaza 2

Vârste de la 18 la 55 · Toate sexele · Actualizat 22 sept. 2026 · NCT07410507

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Neurocrine Clinical Site, Augusta

În curs de recrutareFaza 4

Vârste de 18 ani și peste · Toate sexele · Actualizat 18 sept. 2026 · NCT07105111

A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia

CenExel iResearch, LLC, Decatur

În curs de recrutareFaza 1

Vârste de la 18 la 55 · Toate sexele · Actualizat 17 sept. 2026 · NCT07734493

52-week Open Label Safety-Tolerability Study

CenExel, Atlanta
Accelerated Clinical Trial, Snellville

În curs de recrutareFaza 3

Vârste de la 18 la 65 · Toate sexele · Actualizat 9 sept. 2026 · NCT07369154

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

Atlanta Center for Medical Research, Atlanta
Salveo Integrative Health - Lawrenceville, Lawrenceville
Denali Health Atlanta, LLC, Stone Mountain

În curs de recrutareFaza 3

Vârste de la 13 la 17 · Toate sexele · Actualizat 4 sept. 2026 · NCT07288567

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

Atlanta Center for Medical Research, Atlanta
CenExel iResearch, LLC, Decatur

În curs de recrutareFaza 1

Vârste de la 18 la 55 · Toate sexele · Actualizat 2 sept. 2026 · NCT07061288

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

Clinical Site, Atlanta
Clinical Site, Decatur

În curs de recrutareFaza 2

Vârste de la 18 la 65 · Toate sexele · Actualizat 1 sept. 2026 · NCT07459647

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

Emory University., Atlanta
Local Institution - 0049, Austell
Local Institution - 0044, Marietta

În curs de recrutareStudiu observațional

Vârste de 18 ani și peste · Toate sexele · Actualizat 19 aug. 2026 · NCT07379827

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

Alkermes Investigator Site, Decatur

În curs de recrutareFaza 3

Vârste de la 10 la 17 · Toate sexele · Actualizat 14 aug. 2026 · NCT05303064

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

Bioxcel Clinical Research Site, Decatur

În curs de recrutareFaza 1

Vârste de la 10 la 17 · Toate sexele · Actualizat 11 aug. 2026 · NCT05025605

Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia

CenExel iResearch, Decatur

În curs de recrutareFaza 2

Vârste de la 18 la 65 · Toate sexele · Actualizat 29 iul. 2026 · NCT07467993

Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia

Accelerated Clinical Trial, Snellville

În curs de recrutareFaza 3

Vârste de la 18 la 65 · Toate sexele · Actualizat 27 iul. 2026 · NCT07363577

A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

Cenexel ACMR, Atlanta
Cenexel iResearch Atlanta, Decatur

În curs de recrutareFaza 2

Vârste de la 18 la 55 · Toate sexele · Actualizat 23 iun. 2026 · NCT07191483

Anti-Inflammatory Challenge in Schizophrenia

Grady Memorial Hospital, Atlanta
Emory University Hospital, Atlanta

În curs de recrutareFaza 4

Vârste de la 18 la 55 · Toate sexele · Actualizat 3 iun. 2026 · NCT05823532

CLOZAPINE Response in Biotype-1

University of Georgia, Athens

În curs de recrutareFaza 4

Vârste de la 18 la 60 · Toate sexele · Actualizat 11 mai 2026 · NCT04580134

Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial

Augusta University Research Institute, Inc., Augusta

În curs de recrutareFaza 4

Vârste de la 18 la 65 · Toate sexele · Actualizat 4 mai 2026 · NCT05208190

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

University of Georgia, Athens

În curs de recrutareStudiu observațional

Vârste de la 18 la 40 · Toate sexele · Actualizat 10 mar. 2026 · NCT06740383

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Neurocrine Clinical Site, Atlanta
Neurocrine Clinical Site, Decatur
Neurocrine Clinical Site, Snellville

În curs de recrutareFaza 3

Vârste de la 18 la 65 · Toate sexele · Actualizat 6 mar. 2026 · NCT06963034

Randomized Withdrawal Study in Patients With Schizophrenia

Vanda Investigational Site, Atlanta
Vanda Investigational Site, Peachtree Corners

În curs de recrutareFaza 3

Vârste de la 18 la 65 · Toate sexele · Actualizat 12 ian. 2026 · NCT06961968

Study of ALTO-101 in Patients With Schizophrenia

Site 5064, Snellville

În curs de recrutareFaza 2

Vârste de la 21 la 55 · Toate sexele · Actualizat 26 dec. 2025 · NCT06502964

Cognitive Training for Emotion Regulation in Psychotic Disorders

University of Georgia, Athens

În curs de recrutare

Vârste de la 18 la 60 · Toate sexele · Actualizat 5 feb. 2025 · NCT04414215

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

Reviva site, Atlanta
Reviva site, Decatur

În curs de recrutareFaza 3Voluntari sănătoși bineveniți

Vârste de la 18 la 65 · Toate sexele · Actualizat 19 dec. 2024 · NCT05184335

Sursă: ClinicalTrials.gov, date preluate la 3 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.